Zobrazeno 1 - 10
of 12
pro vyhledávání: '"11"'
Autor:
Rodrigo E. Mendes, Lalitagauri M. Deshpande, Helio S. Sader, Mariana Castanheira, Timothy B Doyle
Publikováno v:
International Journal of Antimicrobial Agents. 58:106439
We investigated the prevalence, resistance mechanisms and activity of ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam and comparator agents against carbapenem-resistant Enterobacterales (CRE) that did not carry carbapenemase genes.
Autor:
Rémy A. Bonnin, Angela Famiglietti, Carlos Vay, Marcela Nastro, Laura Dabos, Carlos Hernán Rodríguez, Laurent Dortet, Bogdan I. Iorga, Thierry Naas
Publikováno v:
International Journal of Antimicrobial Agents
International Journal of Antimicrobial Agents, Elsevier, 2020, 55 (2), pp.105857. ⟨10.1016/j.ijantimicag.2019.11.014⟩
International Journal of Antimicrobial Agents, Elsevier, 2020, 55 (2), pp.105857. ⟨10.1016/j.ijantimicag.2019.11.014⟩
Carbapenemase-producing Enterobacterales expressing OXA-48, KPC, NDM, VIM or IMP enzymes are increasingly reported worldwide. We have characterized LMB-1, a novel metallo-β-lactamase (MBL) of Ambler class B3 from Citrobacter freundii 164 (Cf164) cli
Autor:
Inés Olarte, Esther Undabeitia, Sergio Somalo, Yolanda Sáenz, Myriam Zarazaga, Beatriz Rojo-Bezares, Carmen Torres, Laura Vinué
Publikováno v:
International Journal of Antimicrobial Agents. 35:492-496
The prevalence and characterisation of integrons and the genetic environment of sulphonamide resistance genes were studied in 135 Escherichia coli isolates recovered from blood cultures in a Spanish hospital during 2007. Class 1 and 2 integrons were
Autor:
Hong Lu, Haiyang Liu, Xiaoxiao Zhang, Chong Wang, Lijiang Chen, Hong Wen, Tieli Zhou, Yizhi Zhang, Fang Wang
Publikováno v:
International Journal of Antimicrobial Agents. 52:226-232
The aim of this study was to investigate mechanisms of nitrofurantoin resistance and epidemiological characteristics in Escherichia coli clinical isolates. From a total of 1444 E. coli clinical isolates collected from our hospital in 2015, 18 (1.2%)
Autor:
Zi-Xian Huang, Hanyu Wang, Rong Zhang, Yanyan Hu, Qiaoling Sun, Yue-ling Wang, Gong-Xiang Chen
Publikováno v:
International Journal of Antimicrobial Agents. 50:593-597
The aim of this study was to determine the prevalence and transmission mechanism(s) of mcr-1 in the gut flora of children. Faecal samples (n = 173) were obtained from non-diarrhoea patients at the Children's Hospital of Zhejiang University (Hangzhou,
Autor:
Hernández-García, M, García-Fernández, S, García-Castillo, M, Melo-Cristino, J, Pinto, M, Gonçalves, E, Alves, V, Costa, E, Ramalheira, E, Sancho, L, Diogo, J, Ferreira, R, Silva, T, Chaves, C, Pássaro, L, Paixão, L, Romano, J, Cantón, J, STEP Study Group
Publikováno v:
International Journal of Antimicrobial Agents. 57:106259
Ceftolozane-tazobactam (C/T) is frequently used for infections caused by multidrug-resistant (MDR)-Enterobacterales isolates. Whole-genome sequencing (WGS, Illumina-Hiseq 4000/NovaSeq 6000, OGC, UK) was used to study the population structure, the res
Autor:
Evangelos J. Giamarellos-Bourboulis, Mark Pimentel, Irene Galani, Charalambos Barbatzas, Aikaterini Pistiki, Emmanouel Pyleris
Publikováno v:
International Journal of Antimicrobial Agents. 43:236-241
Rifaximin, a non-absorbable rifamycin derivative, has published clinical efficacy in the alleviation of symptoms in patients with irritable bowel syndrome (IBS). Small intestinal bacterial overgrowth (SIBO) is associated with the pathogenesis of IBS.
Autor:
Lin Lin, Jun-En Lin, Jun-Wei Huang, Po-Liang Lu, Sung-Pin Tseng, Tsung-Ying Yang, Ya-Ju Hsieh
Publikováno v:
International journal of antimicrobial agents. 48(5)
Although fosfomycin is a treatment option for infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae, fosfomycin resistance has been documented. To our knowledge, fosfomycin resistance mechanisms in Klebsiella pneumon
Autor:
José Campos, Antonio Oliver, Rafael Cantón, Jesús Oteo, Elisenda Miró, Carlos Juan, Ferran Navarro, María Pérez-Vázquez, Verónica Bautista, Bartolomé Moyá, Ângela Novais, Karol Diestra, Teresa M. Coque
Publikováno v:
International Journal of Antimicrobial Agents
International Journal of Antimicrobial Agents, Elsevier, 2009, 34 (2), pp.173. ⟨10.1016/j.ijantimicag.2009.03.006⟩
International Journal of Antimicrobial Agents, Elsevier, 2009, 34 (2), pp.173. ⟨10.1016/j.ijantimicag.2009.03.006⟩
In this study, we investigated the population structure of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli in Spain and determined possible associations between specific multilocus sequence typing (MLST) types and ESBL types. Ninet
Autor:
Angelos Stefos, George N. Dalekos, Ergina Malli, Efthymia Petinaki, Angeliki Mavroidi, Vivi Miriagou, Leonidas S. Tzouvelekis
Publikováno v:
International journal of antimicrobial agents. 39(3)
Fifteen carbapenem-non-susceptible Escherichia coli isolates obtained during the period May 2010 to April 2011 in a hospital and a long-term care facility (LTCF) in Larissa (Central Greece) were investigated. Minimum inhibitory concentrations (MICs)